Trading Records for Second Quarter 2026Select June 2026 Highlights* (See tables 1-1C and table 2)Total credit trading volumes showed continued strengt...
Wells Fargo analyst Alec Brondolo maintains AppLovin (NASDAQ:APP) with a Overweight and raises the price target from $571 to $575.
Wells Fargo analyst Steven Cahall maintains Comcast (NASDAQ:CMCSA) with a Underweight and lowers the price target from $29 to $28.
Wolfe Research analyst Rudy Li initiates coverage on LB Pharmaceuticals (NASDAQ:LBRX) with a Outperform rating and announces Price Target of $45.
Wells Fargo analyst Steven Cahall maintains Charter Communications (NASDAQ:CHTR) with a Underweight and lowers the price target from $170 to $160.
New 6-month data supports COMP360’s potential to establish a new standard of care in TRDData from positive COMP006 Phase 3 trial demonstrates durable ...
Benchmark analyst Robert Wasserman upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Hold to Buy and announces $185 price target.
Solstice (SOLS) stock edges up premarket after a 15% plunge on its $14.5B Element Solutions buyout. Get the latest technicals.
Parsons has been awarded a three-year contract to provide program management, construction management, and construction supervision for the Lusail Cit...
Truist Securities analyst Keith Hughes downgrades Amrize (NYSE:AMRZ) from Buy to Hold and lowers the price target from $65 to $48.
The industrials sector presents buying opportunities with oversold stocks. RSI compares strength on up & down days, giving short-term insight.
The collaboration will combine FTAI's engine maintenance capabilities with AEI's cargo conversion leadership to deliver customized freighter a...
Needham analyst Mike Cikos maintains Palo Alto Networks (NASDAQ:PANW) with a Buy and raises the price target from $350 to $425.
This acquisition would expand Equifax into the fast-growth Mexico market, the second-largest economy in Latin America, and offer Círculo de Crédito cu...
B of A Securities analyst Tal Liani reinstates Figma (NYSE:FIG) with a Buy and announces $30 price target.
We're In (The Early Stages Of) A Bubble
2 days agoAnalyst Clem Chambers explains the market's big shuffle, AI's value chain and highlights a rare earth pick.
Needham analyst John Todaro maintains TeraWulf (NASDAQ:WULF) with a Buy and raises the price target from $28 to $33.
(Bloomberg) -- SpaceX is winning early backing from Wall Street as global brokerages launch coverage of Elon Musk’s rocket and artificial intelligence...
HC Wainwright & Co. analyst Matthew Caufield reiterates LENZ Therapeutics (NASDAQ:LENZ) with a Buy and maintains $38 price target.
Loading...
